PAN: Sickle Cell Disease (Medicare)
Patient Access Network Foundation
The PAN: Sickle Cell Disease (Medicare) program offers up to a $2000 annual benefit for medications to patients with sickle cell disease who have Medicare/Medicaid and reside in the US or Puerto Rico. It is a needs-based program, but it is currently not funded.
- Covers
- financial assistance
- Max award
- $2,000
- Enrollment cycle
- as_funded
Eligibility
Patients must have Medicare or Medicaid insurance and a valid sickle cell disease diagnosis to qualify for this $2,000 annual benefit. The program is restricted to residents of the United States and Puerto Rico and is defined as a needs-based assistance fund.
Apply
Application goes directly to Patient Access Network Foundation. RxCopays does not receive compensation.
Go to application →Status source
PAN: Sickle Cell Disease (Medicare) Not Funded
Rare-disease support beyond financial help
This grant covers a rare condition. For specialists, clinical trials, and patient communities, our sister site UniteRare.org has in-depth pages: